Dr. Uday Saxena was “Mentor –in-Residence” and Professor of Translational Research at Dr. Reddy’s Institute of Life Sciences as well as Co-Founder of start-up Biotech Company.

He has held Executive and Leadership positions at Parke-Davis, AtheroGenics, Dr. Reddy’s Laboratories and Kareus Therapeutics.

He is responsible for leading teams that brought several drug candidates from idea into the clinic.

He received his PhD in Biochemistry from Memorial University, Canada and Post-doctoral training at Columbia University.

His current research interests are translational research in metabolic diseases and cancer.

His passion is to continue being an entrepreneur having initiated biotech companies in the US and India.